FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Kronox Lab Sciences IPO and TBO Tek IPO.
Kronox Lab Sciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while TBO Tek IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Kronox Lab Sciences IPO | TBO Tek IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Pantomath Capital Advisors Pvt Ltd | Axis Capital Limited Jefferies India Private Limited Goldman Sachs (India) Securities Private Limited Jm Financial Limited |
Registrar | Kfin Technologies Limited | Kfin Technologies Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Kronox Lab Sciences IPO is up to ₹130.15 Cr whereas the issue size of the TBO Tek IPO is up to ₹1,550.81 Cr. The final issue price of Kronox Lab Sciences IPO is ₹136.00 per share and of TBO Tek IPO is ₹920.00 per share.
Kronox Lab Sciences IPO | TBO Tek IPO | |
---|---|---|
Face Value | ₹10 per share | ₹1 per share |
Issue Price (Lower) | ₹129.00 per share | ₹875.00 per share |
Issue Price (Upper) | ₹136.00 per share | ₹920.00 per share |
Issue Price (Final) | ₹136.00 per share | ₹920.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 110 shares | 16 shares |
Fresh Issue Size | 43,47,826 shares | |
Fresh Issue Size (Amount) | up to ₹400.00 Cr | |
OFS Issue Size | 95,70,000 shares | 1,25,08,797 shares |
OFS Issue Size (Amount) | up to ₹130.15 Cr | up to ₹1,150.81 Cr |
Issue Size Total | 95,70,000 shares | 1,68,56,623 shares |
Issue Size Total (Amount) | up to ₹130.15 Cr | up to ₹1,550.81 Cr |
Kronox Lab Sciences IPO opens on Jun 03, 2024, while TBO Tek IPO opens on May 08, 2024. The closing date of Kronox Lab Sciences IPO and TBO Tek IPO is Jun 05, 2024, and May 10, 2024, respectively.
Kronox Lab Sciences IPO | TBO Tek IPO | |
---|---|---|
Anchor Bid Date | May 31, 2024 | May 07, 2024 |
Issue Open | Jun 03, 2024 | May 08, 2024 |
Issue Close | Jun 05, 2024 | May 10, 2024 |
Basis Of Allotment (Tentative) | Jun 06, 2024 | May 13, 2024 |
Initiation of Refunds (Tentative) | Jun 07, 2024 | May 14, 2024 |
Credit of Share (Tentative) | Jun 07, 2024 | May 14, 2024 |
Listing date (Tentative) | Jun 10, 2024 | May 15, 2024 |
Anchor Lockin End date 1 | Jul 06, 2024 | Jun 12, 2024 |
Anchor Lockin End date 2 | Sep 04, 2024 | Aug 11, 2024 |
Kronox Lab Sciences IPO P/E ratio is 30.37, as compared to TBO Tek IPO P/E ratio of 64.58.
Kronox Lab Sciences IPO | TBO Tek IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Kronox Lab Sciences Limited Financial Information (Restated)Kronox Lab Sciences Limited's revenue increased by 16.99% and profit after tax (PAT) rose by 21.94% between the financial year ending with March 31, 2023 and March 31, 2022.
|
TBO Tek Limited Financial Information (Restated Consolidated)TBO Tek Limited's revenue increased by 112.09% and profit after tax (PAT) rose by 340.4% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 99.98% | 51.26% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 74.21% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 30.37 | 64.58 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹504.61 Cr. | ₹9990.08 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 25.66%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 33.15%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹4.48 | ₹14.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 25.66%% | 30.76% |
In the Kronox Lab Sciences IPO retail investors (RII) are offered 33,49,500 shares while in TBO Tek IPO retail investors are offered 33,49,500 shares. Qualified institutional buyers (QIB) are offered 19,14,000 shares in Kronox Lab Sciences IPO and 50,47,204 shares in TBO Tek IPO.
Kronox Lab Sciences IPO | TBO Tek IPO | |
---|---|---|
Anchor Investor Reserveration | 28,71,000 shares | 75,70,807 shares |
Market Maker Reserveration | ||
QIB | 19,14,000 shares | 50,47,204 shares |
NII | 14,35,500 shares | 25,23,602 shares |
RII | 33,49,500 shares | 16,82,401 shares |
Employee | 0 shares | 32,609 shares |
Others | ||
Total | 66,99,000 shares | 92,85,816 shares |
Kronox Lab Sciences IPO subscribed 117.25x in total, whereas TBO Tek IPO subscribed 86.69x.
Kronox Lab Sciences IPO | TBO Tek IPO | |
---|---|---|
QIB (times) | 89.03x | 125.51x |
NII (times) | 301.92x | 50.60x |
Big NII (times) | 322.26x | 55.82x |
Small NII (times) | 261.22x | 40.15x |
RII (times) | 54.24x | 25.72x |
Employee (times) | 17.81x | |
Other (times) | ||
Total (times) | 117.25x | 86.69x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|